2-Propenamide,3-(9-hydroxy-8-methyl-5-oxo-5H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)-, (E)-(9CI) (77165-77-6)

Identification
Name:	2-Propenamide,3-(9-hydroxy-8-methyl-5-oxo-5H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)-, (E)-(9CI)
Synonyms:	5H-Pyrrolo[2,1-c][1,4]benzodiazepine,2-propenamide deriv.; Didehydroanhydroanthramycin
CAS:	77165-77-6
Molecular Formula:	C16H13 N3 O3
Molecular Weight:	0
InChI:	InChI=1/C16H13N3O3/c1-9-2-4-12-14(15(9)21)18-7-11-6-10(3-5-13(17)20)8-19(11)16(12)22/h2-8,21H,1H3,(H2,17,20)/b5-3+
Molecular Structure:
Properties
Flash Point:	314.1°C
Boiling Point:	595.8°C at 760 mmHg
Density:	1.42g/cm³
Refractive index:	1.695
Flash Point:	314.1°C
Safety Data

Other Product

2-Propenamide,3-(11-ethoxy-5,10,11,11a-tetrahydro-9-hydroxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)-N-methyl-(9CI)
5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one,7-[[4,6-dideoxy-3-C-methyl-4-(methylamino)-a-L-mannopyranosyl]oxy]-9-hydroxy-8-methyl-2-(1-propenyl)-,monohydrochloride, (E)- (9CI)
2-Propenamide,3-(10-acetyl-5,10,11,11a-tetrahydro-9,11-dihydroxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)-,[11R-[2(E),11a,11ab]]- (9CI)
2-Propenamide,3-(5,10,11,11a-tetrahydro-9-hydroxy-11-methoxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)-
5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one,7-[[4,6-dideoxy-3-C-methyl-4-(methylamino)-b-D-altropyranosyl]oxy]-10,11-dihydro-11-hydroxy-9-methoxy-8-methyl-2-(1-propenyl)-(9CI)
3-(9-hydroxy-8-methyl-5,11-dioxo-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)propanenitrile
9-hydroxy-11-methoxy-8-methyl-5-oxo-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl acetate
2-Propenamide,N,N-dimethyl-3-[(11R,11aS)-5,10,11,11a-tetrahydro-11-hydroxy-9-methoxy-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl]-,(2E)-
(2E)-3-[(11R,11aS)-9-hydroxy-11-methoxy-8-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl]prop-2-enenitrile
(2E)-3-(9-hydroxy-11-methoxy-8-methyl-5-oxo-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)prop-2-enamide
(+)-N-Methyl-3-(5,10,11,11a-tetrahydro-9-hydroxy-11-methoxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepine-2-yl)propenamide
5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one,7-[[4,6-dideoxy-3-C-methyl-4-(methylamino)-a-L-mannopyranosyl]oxy]-1,10,11,11a-tetrahydro-9,11-dihydroxy-8-methyl-2-(1E)-1-propen-1-yl-,(11R,11aS)-
1H-Pyrrolo[2,1-c][1,4]benzodiazepine-11-sulfinicacid,2-(3-amino-3-oxo-1-propenyl)-5,10,11,11a-tetrahydro-9-hydroxy-8-methyl-5-oxo-,monosodium salt (9CI)
8-chloro-1-(5-methyl-1,3,4-oxadiazol-2-yl)-11,12,13,13a-tetrahydro-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepin-9-one
5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one,1,2,3,10,11,11a-hexahydro-2-hydroxy-11-methoxy- (9CI)
3-(5,11a-Dihydro-9-hydroxy-8-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepine-2-yl)-N-methylpropenamide
5H-1,4-Benzodiazepin-5-one,4-(2-buten-1-yl)-3,4-dihydro-9-hydroxy-
9-hydroxy-4-(prop-2-en-1-yl)-3,4-dihydro-5H-1,4-benzodiazepin-5-one
9H-Imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepin-9-one,8-bromo-11,12,13,13a-tetrahydro-1-(3-methyl-1,2,4-oxadiazol-5-yl)-, (S)- (9CI)
5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one,7-[[4,6-dideoxy-3-C-methyl-4-(methylamino)-a-L-mannopyranosyl]oxy]-1,2,3,10,11,11a-hexahydro-11-methoxy-2-propylidene-(9CI)